EYA4 and esophageal squamous cell carcinoma: As shown in Table 4, using ratios of EYA4 mRNA expression to β-actin with a positive cut-off value of 0.47, testing sensitivities in ESCD and ESCC became 4% and 16%, respectively, and the testing specificity increased to 100%, where no false positive samples were existed in the study.